Stem cells will change medicine

We stand on the threshold of a revolution in stem cells. The understanding and use of these unique cells may lead to breakthroughs in the field of life extension and therapeutic methods that will allow you to treat any chronic disease and regenerate any organs. In this article we will discuss what are stem cells, the future therapy based on stem cells and the latest success stories of their application.

What are stem cells

Stem cells are undecided cells that can transform into certain cells of the heart, neurons, liver, lung, skin and so on, also they can divide and produce more stem cells.

In childhood or youth, these stem cells are abundant and act as a built-in system repair. Often they are attracted to the site of injury or inflammation to treat and restore normal function.

But as we age, our supply of stem cells starts to decrease to 100 or even 10,000 times, depending on the tissues and organs. In addition, the stem cells survive genetic mutations that reduce their quality and effectiveness in the restoration and repair of the body.

A good analogy, so you can imagine the job of stem cells is a group of repairmen in a newly built mansion. While the new mansion, and workers young, they can do everything perfectly. But when they get older and have less of them, the mansion slowly begins to deteriorate and eventually collapses.

But what if we could restore and rejuvenate the population of stem cells?

One option is in the extraction and accumulation of your own autologous adult stem cells at adiposity (or fat) tissue. But these stem cells is less, and their “source” has undergone a variety of mutations.

Many scientists and physicians now prefer an alternative source, obtaining stem cells from the placenta or umbilical cord left over after birth. These stem cells are available in abundance and in no way affecting the cells of the newborn, you can enter into the joints or intravenously, to rejuvenate and revitalize tissues and organs.

These stem cells can be present as chemical factories that produce vital growth factors, which can reduce inflammation, fight autoimmune disorders, increase muscle mass, repairing joints and even to rejuvenate skin and hair.

Future treatment using stem cells

Over the past ten years the number of annual publications on stem cell research increased 40 times. The market for stem cells promises to reach $ 170 billion by 2020.

The increase in RandD initiatives for the development of therapeutic solutions for chronic diseases and growing demand for regenerative treatment methods most strongly pushing the industry.

Here are four of the most promising areas that should pay attention:

Engineering tissues. Tissue engineering uses the body’s own cells for repair, replacement or improvement of the damaged tissues. Patients with different diseases may be treated through transplantation of tissues and organs. However, we are extremely short of donor tissues and organs, and the situation is deteriorating every year due to the aging of the population. Scientists in the field of tissue engineering apply the principles of transplantation, materials science, and bioengineering to create biological substitutes that will restore and maintain normal function of damaged and sick tissues. The area of stem cells is developing rapidly, opening new opportunities for cell therapy and engineered tissues. The use of postnatal stem cells has the potential to seriously change the perspective of tissue engineering.

Stem cells Bank. “At the moment of your birth you probably are at the point of biological perfection,” says Dr. Bob Hariri. “Your system has not yet been exposed to all these harmful stimuli such as electromagnetic radiation, chemicals, biological your code is still not spoiled.” Bank of stem cells allows us to collect stem cells with the original, untouched DNA at birth, to propagate them in large quantities for future doses and then freeze these doses. Hariri found that in addition to umbilical cord blood (blood that is present in the umbilical cord of a newborn), newborn placenta is an organ extremely rich in stem cells. Instead of throwing away the remaining tissue after delivery, the placenta, they can save and to provide therefore the key to a long and healthy life. Hariri has created a company called LifebankUSA, which provides a single cell, which stores stem cells of children. Lifebank isolates, processes and chrysochroinae cells (immersing them in the deep freeze at a temperature of -180 degrees Celsius), keeping them frozen just in case.

Clinical application of MSCS. Mesenchymal stem cell, the major stem cells for cell therapy used in clinics for 10 years. Currently, worldwide flows 344 was a clinical trial at different stages to assess the potential of therapy based on MSCS. From animal models to clinical trials, MSCS promise to treat a variety of diseases, perhaps even cancer.

The parabiosis. The Protocol is simple: healthy people aged 35 years and older receive a transfusion of blood plasma from donors younger than 25 years, and scientists are watching their blood over the next two years, tracking their health and aging. The study, which takes place in San Francisco, paid for by the patient, it costs $ 8,000. The founder of Ambrosia Jesse Karmazin became interested in the creation of the company on the subject of parabiosis after received interesting data from research involving animals: in one study the subjects received a significant rejuvenation of all major organ systems. “Effects persist almost forever,” he says. “It’s like a full update of gene expression”.

As humans we are constantly faced with the bitter fact we have to die. But the key to health and longevity can be laid in our own source code. In the next twenty years, stem cells will change medicine forever, prolong life, and may save your life.

We live in very interesting times. Perhaps to die is not necessary.